26 May 2013
Keywords: extra, aes, gsk, once-daily, pd, drug, uk
Article | 11 September 2006
UK drug major GlaxoSmithKline says that new data demonstrate that a prolonged-release, once-daily, formulation of ropinirole is at least as
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 September 2006
24 May 2013
© 2013 thepharmaletter.com